Lexaria Bioscience share price logo

Lexaria Bioscience

NASDAQ: LEXX

$3.64

+0.15

(+4.30%)

as on

Lexaria Bioscience Stock Performance

as on November 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.50
    $3.96
    downward going graph

    3.85%

    Downside

    8.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.43
    $21.60
    downward going graph

    33.24%

    Downside

    493.41%

    Upside

    downward going graph

Lexaria Bioscience share price movements today

Previous Close
$3.49
Open
$3.50
Volume
363.5K
Market Cap
$7.4M
Day's Low - High
$3.50 - $3.96
52 Week Low - High
$2.43 - $21.60

Lexaria Bioscience Historical Returns

1 Month Return
+ 26.39 %
3 Month Return
-23.37 %
1 Year Return
-76.67 %
3 Year Return
-83.38 %
5 Year Return
-96.21 %

Lexaria Bioscience Stock Fundamentals & Key Indicators

Check Lexaria Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.4M

EPS (TTM)

-5.319

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.66

Industry PE ratio

-3.13

PEG Ratio

-0.01

EBITDA

-7.7M

Revenue (TTM)

194.0K

Profit Margin

100.00%

Return On Equity TTM

-160.72%

Lexaria Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexaria Bioscience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lexaria Bioscience image
Lexaria Bioscience
Buy$7.4M-96.21%-0.66100.00%0.00%
Moderna image
Moderna
Neutral$88.5B-36.16%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Lexaria Bioscience Stock including INR - Dollar returns

The Lexaria Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Lexaria Bioscience investment value today

Current value as on today

₹24,916

Returns

-₹75,084

(-75.08%)

Returns from Lexaria Bioscience Stock

-₹76,667 (-76.67%)

Dollar Impact

₹1,582 (+1.58%)

Analyst Recommendation on Lexaria Bioscience Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Lexaria Bioscience. Average target price of $82.5

Lexaria Bioscience Share Price Target

Get share price movements and forecasts by analysts on Lexaria Bioscience.

What analysts predicted

95.59%UPSIDE

Target Price

$82.5

Current Price

$3.64

Analyzed by

7 Analysts

Target

$82.50

Lexaria Bioscience target price $82.5, a slight upside of 95.59% compared to current price of $3.64. According to 7 analysts rating.

Indian Investors' Interest in Lexaria Bioscience Stock

Search interest for Lexaria Bioscience Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Lexaria Bioscience Quarterly Profit & Loss

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
May 2026
Total Revenue
0
0
0
0
0
0
0
-
0
-
Gross Profit
0
0
0
0
0
0
0
-
0
-
Operating Income
0
-1
-2
-2
-2
-3
-2
-1
-1
-1
EBITDA
0
-1
-2
-2
-2
-3
-2
-1
-1
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
-2
-2
-2
-3
-2
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
0
0
0
Net Income
0
-1
-2
-2
-2
-3
-2
-1
-1
-1
Net Profit Margin
89.01%
82.05%
80.51%
98.52%
100.00%
100.00%
100.00%
0.00%
100.00%
0.00%

Lexaria Bioscience Annual Profit & Loss

All numbers in Millions USD

Aug 2017
Aug 2018
Aug 2019
Aug 2020
Aug 2021
Aug 2022
Aug 2023
Aug 2024
Aug 2025
Total Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-1
-6
-4
-4
-5
-6
-6
-5
-11
EBITDA
-1
-6
-3
-4
-4
-7
-6
-5
-11
Interest Expense
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-6
-4
-4
-4
-7
-6
-5
-11
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-1
-6
-4
-3
-4
-7
-6
-5
-11
Net Profit Margin
50.91%
93.66%
-87.16%
22.02%
75.74%
18.29%
23.86%
82.56%
99.61%

Lexaria Bioscience Quarterly Cash Flow

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
May 2026
Net Income
0
-1
-2
-2
-2
-3
-2
-1
-1
-1
Operating Cash Flow
0
-1
-1
-2
-1
-3
-2
0
-2
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
3
5
-
4
0
1
-
3
3
-
Change in Cash
2
3
-1
1
-1
-1
-2
2
0
-1

Lexaria Bioscience Annual Cash Flow

All numbers in Millions USD

Aug 2017
Aug 2018
Aug 2019
Aug 2020
Aug 2021
Aug 2022
Aug 2023
Aug 2024
Aug 2025
Net Income
-1
-6
-4
-4
-4
-7
-6
-5
-11
Operating Cash Flow
-1
-2
-3
-2
-3
-4
-5
-4
-10
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
3
1
3
2
13
0
1
10
6
Change in Cash
2
0
0
0
9
-5
-4
5
-4

Global Institutional Holdings in Lexaria Bioscience

Check out the Institutions with significant holdings in Lexaria Bioscience.

Funds
Holdings
CHRISTOPHER BUNKA
44.10%
NORTHERN LIGHTS FUND TRUST II
8.61%
Vanguard
0.94%
Fidelity Concord Street Trust
0.62%

Lexaria Bioscience News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 05:30 PM

    -

    Lexaria announces exercise of warrants for approximately $5.9 million in gross proceeds, enhancing working capital.

Insights on Lexaria Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LEXX stock has moved up by 13.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 863.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 268.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 183.92K → 20.0K (in $), with an average decrease of 23.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.44M → -1.99M (in $), with an average decrease of 37.3% per quarter

About Lexaria Bioscience

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
OrganisationLexaria Bioscience
Headquarters100 – 740 McCurdy Road, Kelowna, BC, V1X 2P7, CA
IndustryBiotechnology
CEORichard C. Christopher

Key Management of Lexaria Bioscience

Name

Title

Mr. Richard C. Christopher

CEO & Director

Mr. John M. Docherty M.Sc.

Chairman of the Scientific Advisory Board, Chief Scientific Officer, President & Director

Mr. Michael Shankman CPA

Chief Financial Officer

Ms. Kristin Hamilton

Director of Operations

Ms. Vanessa Carle

Head of Legal

Dr. C. Michael Gibson M.D., M.S.

Chief Medical Advisor & Member of Scientific Advisory Board

FAQs

What is Lexaria Bioscience share price today?

Lexaria Bioscience share price today is $3.64 as on at the close of the market. Lexaria Bioscience share today touched a day high of $3.96 and a low of $3.50.

What is the 52 week high and 52 week low for Lexaria Bioscience share?

Lexaria Bioscience share touched a 52 week high of $21.60 on and a 52 week low of $2.43 on . Lexaria Bioscience stock price today i.e. is closed at $3.64,which is 83.15% down from its 52 week high and 49.79% up from its 52 week low.

What is Lexaria Bioscience's market capitalisation today?

Lexaria Bioscience market capitalisation is $0.00T as on .

How to invest in Lexaria Bioscience Stock (LEXX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lexaria Bioscience on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lexaria Bioscience Stock (LEXX) from India?

Indian investors can start investing in Lexaria Bioscience (LEXX) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Lexaria Bioscience stock (as per the Rupee-Dollar exchange rate as on ). Based on Lexaria Bioscience share’s latest price of $3.64 as on November 3, 2026 at 8:45 am IST, you will get 2.7473 shares of Lexaria Bioscience. Learn more about fractional shares .

What are the returns that Lexaria Bioscience has given to Indian investors in the last 5 years?

Lexaria Bioscience stock has given -96.21% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?